XML 36 R25.htm IDEA: XBRL DOCUMENT v3.7.0.1
Stock-based Compensation (Tables)
3 Months Ended
Mar. 31, 2017
Summary Components of Stock-Based Compensation Expense

The following table summarizes the components of stock-based compensation expense in the condensed consolidated statements of operations for the three months ended March 31, 2017 and 2016:

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2017

 

 

2016

 

Cost of services

 

$

159

 

 

$

175

 

Cost of product sales

 

 

23

 

 

 

12

 

Selling, general and administrative

 

 

1,272

 

 

 

1,078

 

Product development

 

 

70

 

 

 

121

 

Total

 

$

1,524

 

 

$

1,386

 

 

Time-Based Stock Appreciation Rights [Member]  
Summary of Stock Appreciation Rights

A summary of the Company’s time-based SARs for the three months ended March 31, 2017 is as follows:

 

 

 

 

 

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Average

 

 

Aggregate

 

 

 

 

 

 

 

Weighted-

 

 

Remaining

 

 

Intrinsic

 

 

 

Number of

 

 

Average

 

 

Contractual

 

 

Value

 

 

 

Shares

 

 

Exercise Price

 

 

Term (years)

 

 

(In thousands)

 

Outstanding at January 1, 2017

 

 

3,789,394

 

 

$

5.23

 

 

 

 

 

 

 

 

 

Granted

 

 

90,000

 

 

 

8.58

 

 

 

 

 

 

 

 

 

Exercised

 

 

(46,500

)

 

 

4.18

 

 

 

 

 

 

 

 

 

Forfeited or expired

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at March 31, 2017

 

 

3,832,894

 

 

$

5.25

 

 

 

4.36

 

 

$

18,389

 

Exercisable at March 31, 2017

 

 

3,706,527

 

 

$

5.17

 

 

 

4.12

 

 

$

18,448

 

Vested and expected to vest at March 31, 2017

 

 

3,832,894

 

 

$

5.25

 

 

 

4.36

 

 

$

18,389

 

 

Performance-Based Stock Appreciation Rights [Member]  
Summary of Stock Appreciation Rights

A summary of the Company’s performance-based SARs for the three months ended March 31, 2017 is as follows:

 

 

 

 

 

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Average

 

 

Aggregate

 

 

 

 

 

 

 

Weighted-

 

 

Remaining

 

 

Intrinsic

 

 

 

Number of

 

 

Average

 

 

Contractual

 

 

Value

 

 

 

Shares

 

 

Exercise Price

 

 

Term (years)

 

 

(In thousands)

 

Outstanding at  January 1, 2017

 

 

589,424

 

 

$

6.06

 

 

 

 

 

 

 

 

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(6,800

)

 

 

3.06

 

 

 

 

 

 

 

 

 

Forfeited or expired

 

 

(44,611

)

 

 

11.00

 

 

 

 

 

 

 

 

 

Outstanding at March 31, 2017

 

 

538,013

 

 

$

5.85

 

 

 

4.46

 

 

$

3,262

 

Exercisable at March 31, 2017

 

 

538,013

 

 

$

5.85

 

 

 

4.46

 

 

$

3,262

 

Vested and expected to vest at March 31, 2017

 

 

538,013

 

 

$

5.85

 

 

 

4.46

 

 

$

3,262

 

 

Fair Value of Stock Appreciation Rights Estimated

The fair value of each time-based and performance-based SAR award is estimated on the date of grant using the Black-Scholes option pricing model with the assumptions described below. For the periods indicated, the expected volatility was based on the Company’s historical volatility over the expected terms of the SAR awards. Estimated forfeitures were based on voluntary and involuntary termination behavior, as well as analysis of actual forfeitures. The risk-free interest rate was based on the U.S. Treasury yield curve at the time of the grant over the expected term of the SAR grants. The Company did not grant time-based or performance-based SARs during the three months ended March 31, 2016.

 

 

 

Three Months Ended March 31,

 

 

2017

Risk-free interest rate

 

2.10%

Expected life (years)

 

6.0

Estimated volatility factor

 

59.85%

Expected dividends

 

None

 

Time-Based Restricted Stock Units [Member]  
Summary of Restricted Stock Units

A summary of the Company’s time-based RSUs for the three months ended March 31, 2017 is as follows:

 

 

 

Shares

 

 

Weighted-

Average

Grant Date

Fair Value

 

Balance at January 1, 2017

 

 

691,952

 

 

$

8.28

 

Granted

 

 

47,370

 

 

 

8.59

 

Vested

 

 

(342,084

)

 

 

6.90

 

Forfeited or expired

 

 

(1,556

)

 

 

8.03

 

Balance at March 31, 2017

 

 

395,682

 

 

$

9.52

 

 

Performance-Based Restricted Stock Units [Member]  
Summary of Restricted Stock Units

A summary of the Company’s performance-based RSUs for the three months ended March 31, 2017 is as follows:

 

 

 

Shares

 

 

Weighted-

Average

Grant Date

Fair Value

 

Balance at January 1, 2017

 

 

473,608

 

 

$

7.80

 

Granted

 

 

 

 

 

 

Vested

 

 

(214,190

)

 

 

6.78

 

Forfeited or expired

 

 

(37,080

)

 

 

6.83

 

Balance at March 31, 2017

 

 

222,338

 

 

$

8.94

 

 

Performance Units [Member]  
Fair Value of Stock Appreciation Rights Estimated

As the MPUs contain both a performance and service condition, the MPUs have been treated as a series of three separate awards, or tranches, for purposes of recognizing stock-based compensation expense. The Company recognizes stock-based compensation expense on a tranche-by-tranche basis over the requisite service period for that specific tranche. The Company estimated the fair value of the MPUs using a Monte Carlo Simulation Model that used the following assumptions:

 

 

 

Three Months Ended March 31,

 

 

2017

 

2016

Risk-free interest rate

 

0.99% to 1.44%

 

0.51% to 0.83%

Estimated volatility factor

 

30.0% to 33.0%

 

35.0% to 37.0%

Expected dividends

 

None

 

None